bactimicina for sore throat

Generic: benzocaine

Labeler: dlc laboratories, inc.
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name bactimicina for sore throat
Generic Name benzocaine
Labeler dlc laboratories, inc.
Dosage Form LOZENGE
Routes
ORAL
Active Ingredients

benzocaine 15 mg/1

Manufacturer
DLC Laboratories, Inc.

Identifiers & Regulatory

Product NDC 24286-1577
Product ID 24286-1577_1ce6bbd2-305a-f4a2-e063-6394a90ae798
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Marketing Start 2021-12-21
Marketing End 2026-10-31

Pharmacologic Class

Established (EPC)
standardized chemical allergen [epc]
Chemical Structure
allergens [cs]
Physiologic Effect
increased histamine release [pe] cell-mediated immunity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 242861577
Hyphenated Format 24286-1577

Supplemental Identifiers

RxCUI
199071 1110712
UNII
U3RSY48JW5
NUI
N0000185508 N0000175629 N0000184306 M0000728

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bactimicina for sore throat (source: ndc)
Generic Name benzocaine (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 15 mg/1
source: ndc
Packaging
  • 3 BLISTER PACK in 1 BOX (24286-1577-1) / 6 LOZENGE in 1 BLISTER PACK
source: ndc

Packages (1)

Ingredients (1)

benzocaine (15 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1ce6bbd2-305a-f4a2-e063-6394a90ae798", "openfda": {"nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "unii": ["U3RSY48JW5"], "rxcui": ["199071", "1110712"], "spl_set_id": ["d3abce13-cc87-e661-e053-2a95a90a1b7c"], "pharm_class_cs": ["Allergens [CS]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "manufacturer_name": ["DLC Laboratories, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 BLISTER PACK in 1 BOX (24286-1577-1)  / 6 LOZENGE in 1 BLISTER PACK", "package_ndc": "24286-1577-1", "marketing_end_date": "20261031", "marketing_start_date": "20211221"}], "brand_name": "Bactimicina for Sore Throat", "product_id": "24286-1577_1ce6bbd2-305a-f4a2-e063-6394a90ae798", "dosage_form": "LOZENGE", "pharm_class": ["Allergens [CS]", "Cell-mediated Immunity [PE]", "Increased Histamine Release [PE]", "Standardized Chemical Allergen [EPC]"], "product_ndc": "24286-1577", "generic_name": "Benzocaine", "labeler_name": "DLC Laboratories, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Bactimicina for Sore Throat", "active_ingredients": [{"name": "BENZOCAINE", "strength": "15 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_end_date": "20261031", "marketing_start_date": "20211221"}